This post was originally published on this site
https://d1-invdn-com.investing.com/content/pic027492325b980622ff15995cceb833bc.jpeg
Data analytics software provider Amplitude (NASDAQ:AMPL)
will be reporting earnings tomorrow after the bell. Here’s what to expect.
Last quarter Amplitude reported revenues of $70.64 million, up 14.6% year on year, in line with analyst expectations. It was a mixed quarter for the company, with revenue guidance for the next quarter topping analysts’ expectations. On the other hand, its net revenue retention declined and its customer growth decelerated slightly. The company added 127 customers to a total of 2,471.
Is Amplitude buy or sell heading into the earnings? Find out by reading the original article on StockStory.
This quarter analysts are expecting Amplitude’s revenue to grow 9.6% year on year to $71.51 million, slowing down from the 32% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.03 per share.
Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company has a history of exceeding Wall St’s expectations, beating revenue estimates every single time over the past two years on average by 3%.
Looking at Amplitude’s peers in the data and analytics software segment, some of them have already reported Q4 earnings results, giving us a hint of what we can expect. Palantir (NYSE:PLTR) delivered top-line growth of 19.6% year on year, beating analyst estimates by 0.9% and Confluent reported revenues up 26.4% year on year, exceeding estimates by 3.7%. Palantir traded up 11.7% on the results, and Confluent was up 13.7%.
Read the full analysis of Palantir’s and Confluent’s results on StockStory.
There has been positive sentiment among investors in the data and analytics software segment, with the stocks up on average 2.9% over the last month. Amplitude is up 6% during the same time, and is heading into the earnings with analyst price target of $12.9, compared to share price of $13.6.
